HSIC vs NVS
Henry Schein vs Novartis AG — AI-powered side-by-side comparison
| Metric | HSIC | NVS |
|---|
| AI Score |
65
|
73
|
| Price |
$88.16
|
$156.34
|
| P/E Ratio |
25.47×
|
23.66×
|
| ROE |
12.3%
|
30.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
30.3%
|
74.3%
|
| Debt / Equity |
1.21×
|
1.18×
|
| Dividend Yield |
0.0%
|
2.9%
|
| RSI (14) |
60.6
|
55.8
|
| Beta |
0.806
|
0.46
|
| Expected Upside |
+0.7%
|
+2.7%
|
AI Committee View
Current Innellis committee reasoning for HSIC versus NVS.
NVS leads by 8 points.
NVS scores 73/100 (Buy) versus HSIC at 65/100 (Buy).
HSIC Committee View
75% agreement
4 analysts
The primary driver is market regime is bullish (bull market -- normal position sizing). The main limiting factor is growth rate is decelerating quarter over quarter -- the trend line matters more than the level. The committee is constructive but not yet at full conviction.
Bull Case
- 4 consecutive earnings beats -- consistent execution — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
NVS Committee View
100% agreement
5 analysts
The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is 4 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
Bear Case
- MACD histogram negative -- bearish momentum — Technical